Amanda Boroff, APRN

NPI: 1972139160
Total Payments
$6,632
2024 Payments
$1,824
Companies
27
Transactions
347
Medicare Patients
483
Medicare Billing
$72,623

Payment Breakdown by Category

Food & Beverage$6,526 (98.4%)
Education$106.02 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,526 343 98.4%
Education $106.02 4 1.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,358 82 $0 (2024)
Alkermes, Inc. $607.12 32 $0 (2024)
ITI, Inc. $493.22 42 $0 (2023)
Janssen Pharmaceuticals, Inc $490.42 21 $0 (2024)
Supernus Pharmaceuticals, Inc. $483.64 9 $0 (2024)
Neurocrine Biosciences, Inc. $479.14 20 $0 (2024)
Otsuka America Pharmaceutical, Inc. $324.11 19 $0 (2024)
Lundbeck LLC $314.88 14 $0 (2024)
Teva Pharmaceuticals USA, Inc. $305.35 19 $0 (2024)
Corium, LLC $304.76 15 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,824 79 Supernus Pharmaceuticals, Inc. ($467.79)
2023 $1,843 103 ABBVIE INC. ($479.80)
2022 $1,605 88 ABBVIE INC. ($437.11)
2021 $1,361 77 AbbVie Inc. ($307.09)

All Payment Transactions

347 individual payment records from CMS Open Payments — Page 2 of 14

Date Company Product Nature Form Amount Type
10/01/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.79 General
Category: NEUROSCIENCE
09/25/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $22.40 General
Category: PSYCHIATRY
09/17/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.69 General
Category: Central Nervous System
09/16/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $37.25 General
Category: Neuroscience
09/10/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $7.72 General
Category: NEUROSCIENCE
09/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.86 General
Category: PSYCHIATRY
09/03/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $13.19 General
Category: CNS Stimulant for ADHD
08/22/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $31.40 General
Category: Neuropsychiatry
08/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.67 General
Category: NEUROSCIENCE
07/25/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $25.68 General
Category: Neuropsychiatry
07/24/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $26.47 General
Category: PSYCHIATRY
07/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.91 General
Category: NEUROSCIENCE
07/15/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $8.86 General
Category: CNS Stimulant for ADHD
06/12/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $18.28 General
Category: CNS
06/10/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $15.56 General
Category: ANTI-ANXIETY
06/06/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $14.81 General
Category: VILOXAZINE HYDROCHLORIDE
06/04/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $3.63 General
Category: NEUROSCIENCE
05/29/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $29.93 General
Category: PSYCHIATRY
05/28/2024 Tempus AI, Inc Food and Beverage In-kind items and services $16.38 General
05/16/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $23.28 General
Category: CNS Stimulant for ADHD
05/01/2024 Tempus AI, Inc Food and Beverage In-kind items and services $17.91 General
04/30/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $20.71 General
Category: CNS Stimulant for ADHD
04/25/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $29.42 General
Category: Neuropsychiatry
04/24/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $22.31 General
Category: CNS
04/18/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $16.89 General
Category: ANTI-ANXIETY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 112 258 $58,148 $16,502
2022 2 90 119 $26,765 $5,627
2021 4 183 654 $145,719 $42,766
2020 3 98 127 $27,151 $7,727
Total Patients
483
Total Services
1,158
Medicare Billing
$72,623
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 56 129 $36,188 $10,631 29.4%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 56 129 $21,960 $5,871 26.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 59 $16,551 $3,371 20.4%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 45 60 $10,214 $2,256 22.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 75 297 $83,317 $25,875 31.1%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 75 320 $54,474 $14,913 27.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 22 25 $4,768 $1,101 23.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 11 12 $3,161 $877.20 27.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 37 47 $13,185 $3,621 27.5%
90833 Psychotherapy, 30 minutes Office 2020 45 63 $10,724 $3,195 29.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 16 17 $3,242 $910.52 28.1%

About Amanda Boroff, APRN

Amanda Boroff, APRN is a Psychiatric/Mental Health healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1972139160.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Boroff, APRN has received a total of $6,632 in payments from pharmaceutical and medical device companies, with $1,824 received in 2024. These payments were reported across 347 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,526).

As a Medicare-enrolled provider, Boroff has provided services to 483 Medicare beneficiaries, totaling 1,158 services with total Medicare billing of $72,623. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Fort Myers, FL
  • Active Since 03/19/2020
  • Last Updated 03/19/2020
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1972139160

Products in Payments

  • VRAYLAR (Drug) $1,358
  • CAPLYTA (Drug) $560.01
  • ARISTADA (Drug) $530.76
  • INGREZZA (Drug) $479.14
  • INVEGA SUSTENNA (Drug) $471.34
  • Qelbree (Drug) $467.79
  • REXULTI (Drug) $396.87
  • JORNAY PM (Drug) $278.98
  • LATUDA (Drug) $277.29
  • NEUROSTAR TMS THERAPY SYSTEM (Device) $222.76
  • ABILIFY MAINTENA (Drug) $192.88
  • Azstarys (Drug) $178.52
  • Austedo XR (Drug) $142.90
  • AZSTARYS (Drug) $126.24
  • AUSTEDO (Drug) $102.36
  • HETLIOZ (Drug) $89.74
  • Auvelity (Drug) $84.15
  • LYBALVI (Drug) $76.36
  • UZEDY (Drug) $60.09
  • BELSOMRA (Drug) $54.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Fort Myers